Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

27.93 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,641
Open 27.93
Bid (Size) 27.93 (1)
Ask (Size) 28.00 (1)
Prev. Close 27.93
Today's Range 27.93 - 27.93
52wk Range 25.20 - 37.80
Shares Outstanding 5,606,688,356
Dividend Yield 5.87%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment
Via AB Newswire
Exposures COVID-19 Product Safety
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets

Performance

YTD
-6.05%
-6.05%
1 Month
-0.50%
-0.50%
3 Month
+5.08%
+5.08%
6 Month
-5.58%
-5.58%
1 Year
-21.72%
-21.72%

More News

Read More
Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
Via Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
Via InvestorPlace
What the Options Market Tells Us About Pfizer
Via Benzinga
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock
Via The Motley Fool
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
Via The Motley Fool
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Via Benzinga
Topics ETFs
3 Bargain Stocks With the Potential for Mind-Boggling Returns
Via InvestorPlace
MarketBeat Week in Review – 7/1 - 7/5
Via MarketBeat
Topics Economy
Exposures Interest Rates
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
Via The Motley Fool
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Via Benzinga
3 Stock Giants Analysts Are Bullish On Despite Struggles
Via MarketBeat
3 Dividend Stocks That Are Screaming Buys in July
Via The Motley Fool
Upcoming Stock Spinoffs: Should You Pounce or Pass?
Via InvestorPlace
7 Juicy Dividend Stocks That Have Grown for More Than a Decade
Via InvestorPlace
How To Buy Growth Stocks In An Economy That Isn’t Growing
Via Talk Markets
Topics Economy Stocks
Exposures Economy US Equities
AbbVie Stock: A Perfect Dip for Investors to Buy
Via MarketBeat
Topics ETFs
3 Undervalued Stocks Poised for a Jaw-Dropping Breakout
Via InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Via Benzinga
Exposures COVID-19
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
Via MarketBeat
Exposures Product Safety
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.